Among patients with obstructive coronary disease, nonischemic or dual cardiomyopathy is commonly found on cardiac magnetic resonance (CMR) imaging—a combination that is tied to worse clinical outcomes ...

A scorecard of four risk factors can help clinicians determine which patients with nonischemic cardiomyopathy would benefit from an implantable cardioverter defibrillator, researchers have found. The ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In certain patients with an ICD for primary prevention, ...

November 25, 2003 — Results of the Defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation (DEFINITE), the first large-scale trial investigating the use of implantable cardioverter ...

Please provide your email address to receive an email when new articles are posted on . Major adverse events remained common in patients with nonischemic cardiomyopathy implanted with an electronic ...

Longer-term results of the DANISH trial confirm what was seen 4 years earlier: an implantable cardioverter-defibrillator (ICD) does not reduce the risk of all-cause or CV mortality in patients with ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Better imaging ...

The researchers found that women with nonischemic cardiomyopathy and an implantable cardioverter defibrillator had a lower risk for ventricular tachyarrhythmias or death compared to men. HealthDay ...

Sacubitril/valsartan significantly reduces NT-proBNP levels in patients with heart failure with reduced ejection fraction (HFrEF) over 3 years, with no significant changes in sST2 and galectin-3.

On Wednesday, Dr. Michael Graham, St. Louis medical examiner, said former state legislator Cora Faith Walker died of heart disease, specifically nonischemic cardiomyopathy. Courts Reporter ...